About
Established in 2003, Diagnoptics is the pioneer and inventor of cutting edge diagnostic devices that can non-invasively diagnose and assess the risk of diabetes and its complications. Its technological advance in detecting fluorescence of Advanced Glycation Endproducts (AGEs) has led to the invention of the AGE Reader™ - a state of art diagnostic device which can determine the tissue accumulation of AGEs in 30 seconds. Diagnoptics introduced the AGE Reader mu in 2013. This next generation AGE Reader has the same high measurement quality standard and combines this with an innovative design, at a reduced pricelevel. The AGE Reader mu is a perfect tool for diabetologists and family doctors.
Technologies
Cloudflare DNSGmailGoogle AppsYouTubeAdobe Media OptimizerCedexis RadarWordPress.orgVimeoBootstrap FrameworkMobile FriendlyreCAPTCHAGoogle AnalyticsNginxGoogle Tag Manager
Keywords
diabetes screeningcardiovascular risk assessmentmedical technologynoninvasive technologiesmedical equipment manufacturingglycationhealthcare equipment & suppliesclinical validationage-related diseasesage interventionsage accumulation measurementrisk of diabetesmedical deviceage in atherosclerosisclinical validation studiesage measurementmedical equipment and supplies manufacturingdiagnostic deviceage reader apppersonalized caremedical diagnosticsskin tissue analysispatient monitoringservicesvascular healthnon-invasive risk assessmentrisk predictionskin autofluorescence technologypreventive healthcareb2b
Company Information
- Employees5
- Founded2003
Location
4 Aarhusweg, Groningen, Groningen, Netherlands, 9723